Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2011 | 12-2010 | 12-2009 | |
| Sales | 10,167 | 8,538 | 728 |
| Gross Profit | 10,167 | 8,538 | 728 |
| Operating Expenses | 30,912 | 13,953 | 10,713 |
| Operating Income | -20,745 | -5,415 | -9,985 |
| Interest Expense | 1,589 | 1,493 | 1,503 |
| Other Income | 126 | -392 | 314 |
| Pre-tax Income | -22,208 | -7,300 | -11,174 |
| Net Income Continuous | -22,208 | -7,300 | -11,174 |
| Net Income | $-22,208 | $-7,300 | $-11,174 |
| EPS Basic Total Ops | -14.65 | -625.21 | -956.78 |
| EPS Basic Continuous Ops | -14.70 | -625.11 | -956.84 |
| EPS Diluted Total Ops | -14.65 | -625.21 | -956.78 |
| EPS Diluted Continuous Ops | -14.70 | -625.11 | -956.84 |
| EPS Diluted Before Non-Recurring Items | -14.65 | N/A | N/A |
| EBITDA(a) | $-20,437 | $-5,150 | $-9,836 |